These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25010722)

  • 1. Pioglitazone treatment reduces adipose tissue inflammation through reduction of mast cell and macrophage number and by improving vascularity.
    Spencer M; Yang L; Adu A; Finlin BS; Zhu B; Shipp LR; Rasouli N; Peterson CA; Kern PA
    PLoS One; 2014; 9(7):e102190. PubMed ID: 25010722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance.
    Spencer M; Unal R; Zhu B; Rasouli N; McGehee RE; Peterson CA; Kern PA
    J Clin Endocrinol Metab; 2011 Dec; 96(12):E1990-8. PubMed ID: 21994960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.
    Di Gregorio GB; Yao-Borengasser A; Rasouli N; Varma V; Lu T; Miles LM; Ranganathan G; Peterson CA; McGehee RE; Kern PA
    Diabetes; 2005 Aug; 54(8):2305-13. PubMed ID: 16046295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone induces apoptosis of macrophages in human adipose tissue.
    Bodles AM; Varma V; Yao-Borengasser A; Phanavanh B; Peterson CA; McGehee RE; Rasouli N; Wabitsch M; Kern PA
    J Lipid Res; 2006 Sep; 47(9):2080-8. PubMed ID: 16799131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of adipose function in obese glucose-tolerant men following pioglitazone treatment is associated with CCAAT enhancer-binding protein β up-regulation.
    Powell LA; Crowe P; Kankara C; McPeake J; McCance DR; Young IS; Trimble ER; McGinty A
    Clin Sci (Lond); 2012 Aug; 123(3):135-46. PubMed ID: 22309242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation.
    Spencer M; Yao-Borengasser A; Unal R; Rasouli N; Gurley CM; Zhu B; Peterson CA; Kern PA
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E1016-27. PubMed ID: 20841504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone.
    Unal R; Yao-Borengasser A; Varma V; Rasouli N; Labbate C; Kern PA; Ranganathan G
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2993-3001. PubMed ID: 20392866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity.
    Shadid S; Jensen MD
    Diabetes Care; 2003 Nov; 26(11):3148-52. PubMed ID: 14578253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary flaxseed oil reduces adipocyte size, adipose monocyte chemoattractant protein-1 levels and T-cell infiltration in obese, insulin-resistant rats.
    Baranowski M; Enns J; Blewett H; Yakandawala U; Zahradka P; Taylor CG
    Cytokine; 2012 Aug; 59(2):382-91. PubMed ID: 22592037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue collagen VI in obesity.
    Pasarica M; Gowronska-Kozak B; Burk D; Remedios I; Hymel D; Gimble J; Ravussin E; Bray GA; Smith SR
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5155-62. PubMed ID: 19837927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients.
    Koenen TB; Tack CJ; Kroese JM; Hermus AR; Sweep FC; van der Laak J; Stalenhoef AF; de Graaf J; van Tits LJ; Stienstra R
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4453-7. PubMed ID: 19820024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of fish oil and pioglitazone on pancreatic tissue in obese KK mice with type 2 diabetes.
    Iizuka Y; Kim H; Izawa T; Sakurai K; Hirako S; Wada M; Matsumoto A
    Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():53-59. PubMed ID: 27914514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.
    Finlin BS; Bodles-Brakhop AM; Yao-Borengasser A; Zhu B; Starnes CP; McGehee RE; Peterson CA; Kern PA; Rasouli N
    Metab Syndr Relat Disord; 2012 Aug; 10(4):312-7. PubMed ID: 22651256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance.
    Ye L; Liang S; Guo C; Yu X; Zhao J; Zhang H; Shang W
    Life Sci; 2016 Dec; 166():82-91. PubMed ID: 27702567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance.
    Varma V; Yao-Borengasser A; Bodles AM; Rasouli N; Phanavanh B; Nolen GT; Kern EM; Nagarajan R; Spencer HJ; Lee MJ; Fried SK; McGehee RE; Peterson CA; Kern PA
    Diabetes; 2008 Feb; 57(2):432-9. PubMed ID: 18057090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice.
    Fujisaka S; Usui I; Bukhari A; Ikutani M; Oya T; Kanatani Y; Tsuneyama K; Nagai Y; Takatsu K; Urakaze M; Kobayashi M; Tobe K
    Diabetes; 2009 Nov; 58(11):2574-82. PubMed ID: 19690061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
    de Souza CJ; Eckhardt M; Gagen K; Dong M; Chen W; Laurent D; Burkey BF
    Diabetes; 2001 Aug; 50(8):1863-71. PubMed ID: 11473050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARγ activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats.
    Sato D; Oda K; Kusunoki M; Nishina A; Takahashi K; Feng Z; Tsutsumi K; Nakamura T
    Eur J Pharmacol; 2016 Feb; 773():71-7. PubMed ID: 26825545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects.
    Hammarstedt A; Sopasakis VR; Gogg S; Jansson PA; Smith U
    Diabetologia; 2005 Jan; 48(1):96-104. PubMed ID: 15624096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.